Announcements
- Directors’ / PDMR Dealing and Grant of Options
- Results for the Year ended 31 December 2023
- Notice of Results and Investor Presentation
- Eroxon to be available on prescription
- Trading Update
- Appointment of Joint Corporate Broker
- Director/PDMR Dealing
- Remuneration of Non-Exec Directors & Voting Rights
- Futura Medical extends collaboration with Cooper
- Appointment of Roy Davis as Non-Executive Director
More ▼
Key statistics
As of last trade, Futura Medical PLC (GYX:FRA) traded at 0.372, 40.91% above the 52 week low of 0.264 set on Dec 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.372 |
---|---|
High | 0.372 |
Low | 0.372 |
Bid | 0.386 |
Offer | 0.424 |
Previous close | 0.392 |
Average volume | 222.22 |
---|---|
Shares outstanding | 301.45m |
Free float | 202.32m |
P/E (TTM) | -- |
Market cap | 105.06m GBP |
EPS (TTM) | -0.0219 GBP |
Data delayed at least 15 minutes, as of Apr 30 2024 07:02 BST.
More ▼